MeMed is a leading med tech and bio-convergence company, having developed innovative diagnostic host immune response testing methods that address complex clinical dilemmas and improve patient outcomes. Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders – at the right place and the right time.
Looking for a particular MeMed employee's phone or email?
The MeMed annual revenue was $26 million in 2026.
Eran Eden is the Co-founder and CEO of MeMed.
67 people are employed at MeMed.
MeMed is based in Haifa, Haifa.
The NAICS codes for MeMed are [33, 541, 54, 339].
The SIC codes for MeMed are [38, 382].